2Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].Diabetes.1997,46:3～10.
3Hota misligil-GS, Budavari A, Murray D, et al. Reduce tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role tumor necrosis factor α[J]. J Clin Invest ,1994,94:1543～1549.
4Bastard JP, Maachi M, Nhieu JT van, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro[J]. J Clin Endocrinol Metab, 2002; 87:2084～2089.
5Ookuma M, Ookuma K, York DA, et al. Effects of leptin on insulin secretion from isolated rat pancreatic islets[J]. Diabetes, 1998, 47:219～223.
6McTernan CL, Mc Ternan PG, Herte AL, et al. Resistin, central obesity, and type 2 diabetes[J]. Lancet, 2002, 359:46～47.
7Ravussin E. Energy metabolism in obesity. Studies in the Pima Indians[J]. Diabetes Care, 1993, 16(S1):232～238.
8Zimmet P. The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography[J]. Diabetes Care, 1995, 18:1050～1064.
9Spieth LE, Hamish JD, Lenders CM, et al. A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med, 2000,154:947-951.
10Kevin P, Gregory JN, Karen JC, et al. Diet, physical activity, and sedentary behaviors as risk factors for overweight in adolescence. Arch Pediatr Adolesc Med, 2004,158: 385-391.
